IJU Case Reports最新文献

{"title":"Correction to “Efficacy of Trametinib in a Metastatic Urothelial Carcinoma Patient With a BRAF Mutation: A Case Report”","authors":"","doi":"10.1002/iju5.70047","DOIUrl":"https://doi.org/10.1002/iju5.70047","url":null,"abstract":"<p>H. Karasawa, Y. Yasumizu, T. Kosaka, Shimoi, and M. Oya, “Efficacy of trametinib in a metastatic urothelial carcinoma patientwith a BRAF mutation,” <i>IJU Case Reports</i> 7, no. 5 (2024): 375-378, https://doi.org/10.1002/iju5.12759.</p><p>In the ‘Case presentation’ section, the first two sentences in the second paragraph read as follows: To provide further treatment for this patient, we conducted cancer multigene panel testing (FoundationOne®). We examined 324 cancer-related genes and identified the BRAF G469A mutations (Fig. 2).</p><p>The authors would like to clarify that the cancer panel test was performed at the referring hospital and not at the authors’ hospital. The correct text should be: To provide further treatment for this patient, cancer multigene panel testing (FoundationOne®) was conducted. Analysis of 324 cancer-related genes revealed the BRAF G469A mutation (Fig. 2).</p>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70047","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144524888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Two-Stage Tumor Resection for Locally Advanced Renal Cell Carcinoma With Level IV Tumor Thrombus and Pulmonary Embolism: A Case Report","authors":"Takanari Kambe,&nbsp;Kei Mizuno,&nbsp;Yuki Teramoto,&nbsp;Takayuki Sumiyoshi,&nbsp;Yuki Kita,&nbsp;Kimihiko Masui,&nbsp;Takayuki Goto,&nbsp;Shusuke Akamatsu,&nbsp;Ryoichi Saito,&nbsp;Takashi Kobayashi","doi":"10.1002/iju5.70045","DOIUrl":"https://doi.org/10.1002/iju5.70045","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>We report a case of renal cell carcinoma with an inferior vena cava tumor thrombus extending into the right atrium and pulmonary embolism, treated using a staged surgical approach.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A man in his 60s was diagnosed with left clear cell renal cell carcinoma with a tumor thrombus extending to the right atrium, posing a risk of sudden death. Given the high perioperative risk, complete resection in a single session was infeasible. Preoperative administration of a tyrosine kinase inhibitor showed limited effectiveness, and the patient developed pulmonary embolism. An initial thoracotomy was performed to urgently remove the pulmonary artery and right atrial thrombus, along with as much infra-diaphragmatic thrombus as feasible. This was followed by open radical nephrectomy and abdominal inferior vena cava thrombectomy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The staged approach enabled curative nephrectomy despite the presence of tumor thrombus and pulmonary embolism.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 4","pages":"382-385"},"PeriodicalIF":0.0,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70045","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144524559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metformin-Associated Lactic Acidosis During Docetaxel Therapy for Castration-Resistant Prostate Cancer: A Case Report","authors":"Y. Inoue,&nbsp;A. Niimi,&nbsp;T. Kudo,&nbsp;U. Yoshizaki,&nbsp;Y. Sato,&nbsp;H. Kume","doi":"10.1002/iju5.70055","DOIUrl":"https://doi.org/10.1002/iju5.70055","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Docetaxel is a key treatment for castration-resistant prostate cancer and is administered with prednisolone, which increases the risk of steroid-induced diabetes. Its myelosuppressive effect also increases vulnerability to febrile neutropenia. Metformin is widely used for glycemic control; however, elderly cancer patients are particularly susceptible to metformin-associated lactic acidosis, necessitating careful management of sick-day and febrile neutropenia during chemotherapy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>We report a 70-year-old male with castration-resistant prostate cancer and diabetes mellitus who developed febrile neutropenia on Day 5 following docetaxel initiation. He progressed to shock with severe metabolic acidosis on Day 7 and died despite intensive care, including continuous renal replacement therapy. A retrospective review revealed continued metformin use despite prodromal fatigue and loss of appetite, likely due to impaired judgment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This case may have involved septic shock, but metformin likely worsened the lactic acidosis. It highlights the need for sick-day education and monitoring in elderly cancer patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 4","pages":"411-414"},"PeriodicalIF":0.0,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70055","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144524558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Case of Hemophagocytic Lymphohistiocytosis During Immune Checkpoint Inhibitor Treatment for Metastatic Renal Cell Carcinoma, Complicated by Pancytopenia Attributed to Cytomegalovirus Infection","authors":"Tomoko Honda,&nbsp;Hirohito Naito,&nbsp;Yu Osaki,&nbsp;Yoichiro Tohi,&nbsp;Yuki Matsuoka,&nbsp;Takuma Kato,&nbsp;Homare Okazoe,&nbsp;Rikiya Taoka,&nbsp;Nobufumi Ueda,&nbsp;Mikio Sugimoto","doi":"10.1002/iju5.70058","DOIUrl":"https://doi.org/10.1002/iju5.70058","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Hemophagocytic lymphohistiocytosis (HLH) is characterized by macrophage and cytotoxic lymphocyte hyperactivation, fever, pancytopenia, liver dysfunction, and abnormal coagulation. However, no specific treatments have been established for HLH caused by immune checkpoint inhibitors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A 63-year-old male with clear cell renal carcinoma was treated with pembrolizumab and lenvatinib. Fifteen days later, he developed pancytopenia, liver and renal impairments, hypofibrinogenemia, hypertriglyceridemia, and elevated ferritin levels. Subsequently, he was admitted to the ICU for respiratory and circulatory instabilities. The patient was diagnosed with HLH and treated with high-dose corticosteroids and mycophenolate mofetil. Pancytopenia persisted and required massive blood transfusions. Cytomegalovirus infection was found to be the cause, and pancytopenia improved with ganciclovir. The patient was discharged from the ICU after 21 days.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>We present the case of a patient who developed HLH as an immune-related adverse event along with a secondary cytomegalovirus infection, resulting in prolonged pancytopenia.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 4","pages":"423-426"},"PeriodicalIF":0.0,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70058","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144524686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transient Azoospermia Induced by Valganciclovir Treatment for Cytomegalovirus Infection in a Reproductive Male After Kidney Transplant: A Case Report","authors":"Kosuke Mieda,&nbsp;Shunta Hori,&nbsp;Mitsuru Tomizawa,&nbsp;Kuniaki Inoue,&nbsp;Tatsuo Yoneda,&nbsp;Yuji Nitta,&nbsp;Yasushi Nakai,&nbsp;Makito Miyake,&nbsp;Nobumichi Tanaka,&nbsp;Kiyohide Fujimoto","doi":"10.1002/iju5.70060","DOIUrl":"https://doi.org/10.1002/iju5.70060","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Spermatogenic dysfunction is a side effect of valganciclovir, which is commonly used to treat cytomegalovirus infections. Here, we report the case of a reproductive man who underwent kidney transplantation and was diagnosed with azoospermia after valganciclovir treatment for cytomegalovirus infection.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A 30-year-old man underwent an ABO-compatible living-donor kidney transplantation. Two months after the kidney transplant, the patient was diagnosed with cytomegalovirus infection and gastritis. Therefore, valganciclovir treatment was initiated. Two months after completion of valganciclovir treatment, the patient was diagnosed with azoospermia. Azoospermia induced by valganciclovir was suspected, and careful monitoring was performed. Nine months after azoospermia diagnosis, the sperm concentration improved to normal range (43.3 × 10⁶/mL). Subsequently, the patient's wife conceived.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>During valganciclovir treatment, careful monitoring and adequate informed consent are needed to support patients of reproductive age.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 4","pages":"431-434"},"PeriodicalIF":0.0,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70060","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144524685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Posterior Reversible Leukoencephalopathy Syndrome and Disseminated Varicella-Zoster Virus Infection After Kidney Transplantation","authors":"Kenji Tsutsui,&nbsp;Shigeaki Nakazawa,&nbsp;Makoto Kinoshita,&nbsp;Yoko Higa,&nbsp;Soichi Matsumura,&nbsp;Shota Fukae,&nbsp;Ryo Tanaka,&nbsp;Norichika Ueda,&nbsp;Yoichi Kakuta,&nbsp;Norio Nonomura","doi":"10.1002/iju5.70030","DOIUrl":"https://doi.org/10.1002/iju5.70030","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Posterior reversible leukoencephalopathy syndrome (PRES) is a rare but serious complication in kidney transplant recipients, often triggered by calcineurin inhibitors (CNIs) and infections.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A 52-year-old woman with end-stage kidney disease underwent cadaveric renal transplantation. Two months post-transplant, she presented with headaches, visual disturbances, hypertension, and altered consciousness. Cranial MRI confirmed PRES. After conversion from tacrolimus to cyclosporine and antihypertensive therapy, symptoms improved. However, the patient developed disseminated varicella-zoster virus infection, resulting in meningitis. Treatment with acyclovir and reduction of immunosuppression led to full recovery without recurrence.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This case highlights the importance of recognizing PRES and its triggers, including infections and CNIs, in kidney transplant recipients. Early diagnosis and appropriate management are crucial for preventing severe outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 4","pages":"330-333"},"PeriodicalIF":0.0,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70030","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144524743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bilateral High Intra-Abdominal Testes Successfully Treated With Multistage Fowler–Stephens Orchiopexy to Preserve Testicular Function","authors":"Akari Hiraguri,&nbsp;Yuichi Sato,&nbsp;Junya Hata,&nbsp;Yusuke Kirihana,&nbsp;Akihisa Hasegawa,&nbsp;Satoru Meguro,&nbsp;Kanako Matsuoka,&nbsp;Seiji Hoshi,&nbsp;Souichiro Ogawa,&nbsp;Yoshiyuki Kojima","doi":"10.1002/iju5.70059","DOIUrl":"https://doi.org/10.1002/iju5.70059","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>A case of bilateral high intra-abdominal testes successfully treated with multistage Fowler–Stephens orchiopexy is reported.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A 6-month-old boy with bilateral nonpalpable testes was diagnosed with a left intra-abdominal testis located immediately caudal to the spleen on magnetic resonance imaging and laparoscopy. At the age of 4 years, diffusion-weighted magnetic resonance imaging detected a structure immediately caudal to the liver, which was suspected to be the right testis. With a diagnosis of bilateral intra-abdominal testes, one-stage Fowler–Stephens orchiopexy was performed on the right testis at 5 years of age. After confirming its development, two-stage Fowler–Stephens orchiopexy was performed on the left testis at 10 years of age.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>After confirming the development of the right testis that underwent one-stage Fowler–Stephens orchiopexy, two-stage Fowler–Stephens orchiopexy was completed on the left testis, resulting in the successful preservation of both testes and normal sexual development.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 4","pages":"427-430"},"PeriodicalIF":0.0,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70059","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144524928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Combination of Neoadjuvant Gemcitabine-Cisplatin and Anti-Tuberculosis Therapy for a Patient With Muscle-Invasive Bladder Cancer and Renal Granulomatosis That Progressed After Intravesical Bacillus Calmette-Guérin Therapy","authors":"Takahiro Tsumori,&nbsp;Seiji Hoshi,&nbsp;Kei Yaginuma,&nbsp;Satoru Meguro,&nbsp;Kanako Matsuoka,&nbsp;Junya Hata,&nbsp;Yuichi Sato,&nbsp;Hidenori Akaihata,&nbsp;Soichiro Ogawa,&nbsp;Yoshiyuki Kojima","doi":"10.1002/iju5.70057","DOIUrl":"https://doi.org/10.1002/iju5.70057","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>A case of muscle-invasive bladder cancer and renal granulomatosis that developed after intravesical Bacillus Calmette-Guérin therapy, in which a combination of neoadjuvant gemcitabine-cisplatin and anti-tuberculosis therapy was safely administered, and radical cystectomy was ultimately performed, is reported.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A 64-year-old man with non-muscle-invasive bladder cancer underwent transurethral resection and intravesical Bacillus Calmette-Guérin therapy every time bladder cancer recurred. However, the patient developed left renal granulomatosis during treatment. Anti-tuberculosis therapy was prioritized since there was no bladder cancer progression. However, local bladder cancer progression was observed during the anti-tuberculosis therapy. To successfully cure the renal granulomatosis and suppress tumor progression, neoadjuvant gemcitabine-cisplatin was combined with anti-tuberculosis therapy for 2 months, followed by radical cystectomy. There were no gemcitabine-cisplatin complications and no renal granulomatosis recurrence during combination therapy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Combination of gemcitabine-cisplatin and anti-tuberculosis therapy was possible for a patient with bladder cancer when Bacillus Calmette-Guérin infection was under control.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 4","pages":"419-422"},"PeriodicalIF":0.0,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70057","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144525176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intravenous Lobular Capillary Hemangioma in the Renal Vein Mimicking Renal Cancer","authors":"Keisuke Ueki,&nbsp;Hideaki Ito,&nbsp;Takafumi Kabuto,&nbsp;Yasuharu Kaizaki,&nbsp;Ishida Takuya,&nbsp;Tadahiro Kobayashi","doi":"10.1002/iju5.70054","DOIUrl":"https://doi.org/10.1002/iju5.70054","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Lobular capillary hemangioma is a benign tumor that commonly occurs in the skin and mucous membranes. A lobular capillary hemangioma that occurs within blood vessels is called intravenous lobular capillary hemangioma. In this report, we report the fifth case of intravenous lobular capillary hemangioma originating from a renal vessel.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A 68-year-old man was diagnosed with right renal cell carcinoma with right renal vein tumor thrombus on computed tomography examination for asymptomatic aortic valve stenosis. The patient underwent a robot-assisted laparoscopic radical right nephrectomy and was diagnosed with intravenous lobular capillary hemangioma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>It is thought that surgical treatment is necessary to differentiate intravenous lobular capillary hemangioma from renal cell carcinoma in preoperative examinations.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 4","pages":"406-410"},"PeriodicalIF":0.0,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70054","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144525174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percutaneous Transretropubic Needle Prostatic Biopsy Under US and CT Guidance","authors":"Maki Hirao,&nbsp;Hideki Ishimaru,&nbsp;Satomi Yoshimi,&nbsp;Takamasa Nishimura,&nbsp;Taiga Oka,&nbsp;Chika Somagawa,&nbsp;Tomoki Nakano,&nbsp;Ryoichi Imamura,&nbsp;Ryo Toya","doi":"10.1002/iju5.70056","DOIUrl":"https://doi.org/10.1002/iju5.70056","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>No previous instances of percutaneous transretropubic prostate biopsy have been documented.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A 74-year-old male patient with a permanent stoma, who had undergone colectomy for descending colon cancer two decades earlier, reported experiencing dysuria. A screening examination revealed an elevated prostate-specific antigen level of 120.24 ng/mL. Despite an intact rectum, the patient's anus was severely constricted or blocked, preventing both digital rectal examination and the insertion of a transrectal ultrasound probe. A transabdominal ultrasound-guided transretropubic prostate biopsy was conducted while monitoring the needle tip position using computed tomography. The subsequent pathological analysis confirmed prostatic adenocarcinoma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This case represents the first reported instance of a percutaneous transretropubic prostate biopsy.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 4","pages":"415-418"},"PeriodicalIF":0.0,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70056","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144525175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}